FIELD: medicine.
SUBSTANCE: method involves the peripheral blood analysis for T-lymphocyte count with receptor expression in relation to CD3+ and CD25+ cells by cell count in 1 mcl of blood before the beginning of treatment and 10 days after. If observing the count increased 7% and more in comparison with the reference, a therapeutic effect in non-psychotic versions of psycho-organic syndrome is predicted to be positive.
EFFECT: use of the method enables more precise prediction of the clinical effectiveness in the given disease that promotes selecting an adequate therapy and reducing length of treatment.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN NON-PSYCHOTIC VERSIONS OF PSYCHO-ORGANIC SYNDROME | 2012 |
|
RU2497125C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN NON-PSYCHOTIC VERSIONS OF PSYCHO-ORGANIC SYNDROME | 2011 |
|
RU2465603C1 |
| METHOD OF TREATMENT EFFICIENCY FORECASTING OF WITH NEUROPROTECTORS OF NON-PSYCHOTIC VERSIONS OF PSYCHOORGANIC SYNDROME | 2007 |
|
RU2352946C1 |
| METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
| METHOD FOR PREDICTION OF PULMONARY TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2012 |
|
RU2504787C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RELAPSE IN THE MEDICAL TREATMENT OF GRAVES' DISEASE | 2021 |
|
RU2778614C1 |
| CYTOMETRIC METHOD FOR PREDICTION OF CLINICAL OUTCOME OF WIDESPREAD PURULENT PERITONITIS | 2018 |
|
RU2691742C1 |
| METHOD FOR PREDICTING CLINICAL EFFECTIVENESS IN SEVERE GESTOSES | 2008 |
|
RU2377569C1 |
| METHOD OF PREDICTING STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT INDICATORS OF IMMUNOLOGICAL STATUS | 2023 |
|
RU2811481C1 |
| METHOD FOR PREDICTION OF EARLY RECURRENCE IN PATIENTS WITH CLASSICAL HODGKIN'S LYMPHOMA | 2019 |
|
RU2702360C1 |
